
TY  - JOUR
AU  - Conrad, Marcel E.
AU  - Umbreit, Jay N.
TI  - Iron absorption: Relative importance of iron transport pathways
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 67
IS  - 3
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.1114
DO  - doi:10.1002/ajh.1114
SP  - 215
EP  - 215
PY  - 2001
ER  - 

TY  - JOUR
AU  - Kizaki, Masahiro
AU  - Takayama, Nobuyuki
AU  - Kawai, Yohko
AU  - Okamoto, Shin-ichiro
AU  - Ikeda, Yasuo
TI  - Development of acute erythremia from myelodysplastic syndrome after treatment with 1,25-dihydroxyvitamin D3
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 67
IS  - 3
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.1115
DO  - doi:10.1002/ajh.1115
SP  - 215
EP  - 216
PY  - 2001
ER  - 

TY  - JOUR
AU  - Ruggeri, Marco
AU  - Tosetto, Alberto
AU  - Castaman, Giancarlo
AU  - Rodeghiero, Francesco
TI  - Pulmonary embolism after pregnancy in a patient with polycythemia vera
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 67
IS  - 3
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.1116
DO  - doi:10.1002/ajh.1116
SP  - 216
EP  - 217
PY  - 2001
ER  - 

TY  - JOUR
AU  - Powari, Manish
AU  - Joshi, Kusum
AU  - Dutta, Usha
TI  - Case of plasma-cell dyscrasia in a 13-year-old girl
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 67
IS  - 3
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.1117
DO  - doi:10.1002/ajh.1117
SP  - 217
EP  - 217
PY  - 2001
ER  - 

TY  - JOUR
AU  - Shvidel, Lev
AU  - Klepfish, Abraham
AU  - Berrebi, Alain
TI  - Successful treatment with rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low-grade non-Hodgkin's lymphoma
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 67
IS  - 3
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.1112
DO  - doi:10.1002/ajh.1112
SP  - 213
EP  - 214
PY  - 2001
ER  - 

TY  - JOUR
AU  - Aledort, Louis M.
TI  - Adverse reactions related to rVIIa?
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 67
IS  - 3
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.1111
DO  - doi:10.1002/ajh.1111
SP  - 213
EP  - 213
PY  - 2001
ER  - 

TY  - JOUR
AU  - Schrader, Elinor S
AU  - Patterson, Patricia
TI  - Surgeons summarize progress
JO  - AORN Journal
JA  - AORN Journal
VL  - 33
IS  - 1
SN  - 0001-2092
UR  - https://doi.org/10.1016/S0001-2092(07)69392-2
DO  - doi:10.1016/S0001-2092(07)69392-2
SP  - 73
EP  - 78
PY  - 1981
ER  - 

TY  - JOUR
TI  - Cytomics and the human cytome project
JO  - Cytometry Part A
JA  - Cytometry
VL  - 71A
IS  - 1
SN  - 1552-4922
UR  - https://doi.org/10.1002/cyto.a.20372
DO  - doi:10.1002/cyto.a.20372
SP  - 46
EP  - 60
PY  - 2007
ER  - 

TY  - JOUR
TI  - Normal and neoplastic hematopoiesis
JO  - Journal of Cellular Biochemistry
JA  - J. Cell. Biochem.
VL  - 21
IS  - S7B
SN  - 0730-2312
UR  - https://doi.org/10.1002/jcb.240210602
DO  - doi:10.1002/jcb.240210602
SP  - 1
EP  - 65
PY  - 1983
ER  - 

TY  - JOUR
TI  - Oral Abstract
JO  - American Journal of Transplantation
JA  - Am J Transplant
VL  - 16
IS  - S3
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.13897
DO  - doi:10.1111/ajt.13897
SP  - 203
EP  - 404
PY  - 2016
ER  - 

C7  - pp. 141-162
TI  - Systemic Diseases Affecting the Salivary Glands
SN  - 9781118933756
UR  - https://doi.org/10.1002/9781118949139.ch6
DO  - doi:10.1002/9781118949139.ch6
SP  - 141-162
KW  - Sjogren disease
KW  - Mikulicz disease
KW  - sarcoidosis
KW  - sialosis
KW  - lymphoepithelial lesion
KW  - salivary gland biopsy
PY  - 2016
AB  - Summary A number of autoimmune systemic diseases can result in infiltration of the salivary glands. These diseases include Sjogren disease, sialosis, sarcoidosis, and lymphoepithelial lesions. This chapter will review these systemic diseases as well as their presentation and treatment of salivary gland enlargement.
ER  - 

TY  - JOUR
TI  - SSI 2017 44th Annual Meeting of the Scandinavian Society of Immunology Stockholm, Sweden 17–20 October 2017
JO  - Scandinavian Journal of Immunology
JA  - Scand J Immunol
VL  - 86
IS  - 4
SN  - 9781118933756
UR  - https://doi.org/10.1111/sji.12587
DO  - doi:10.1111/sji.12587
SP  - 249
EP  - 350
PY  - 2017
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - International Journal of Laboratory Hematology
VL  - 30
IS  - s1
SN  - 9781118933756
UR  - https://doi.org/10.1111/j.1751-553X.2008.01061.x
DO  - doi:10.1111/j.1751-553X.2008.01061.x
SP  - 1
EP  - 57
PY  - 2008
ER  - 

TY  - JOUR
AU  - Planas, R.
AU  - Carrillo, J.
AU  - Sanchez, A.
AU  - Ruiz de Villa, M. C.
AU  - Nuñez, F.
AU  - Verdaguer, J.
AU  - James, R. F. L.
AU  - Pujol-Borrell, R.
AU  - Vives-Pi, M.
TI  - Gene expression profiles for the human pancreas and purified islets in Type 1 diabetes: new findings at clinical onset and in long-standing diabetes
JO  - Clinical & Experimental Immunology
VL  - 159
IS  - 1
SN  - 9781118933756
UR  - https://doi.org/10.1111/j.1365-2249.2009.04053.x
DO  - doi:10.1111/j.1365-2249.2009.04053.x
SP  - 23
EP  - 44
KW  - autoimmunity
KW  - human
KW  - islets
KW  - pancreas
KW  - T1D
KW  - transcriptome
PY  - 2010
AB  - Summary Type 1 diabetes (T1D) is caused by the selective destruction of the insulin-producing ? cells of the pancreas by an autoimmune response. Due to ethical and practical difficulties, the features of the destructive process are known from a small number of observations, and transcriptomic data are remarkably missing. Here we report whole genome transcript analysis validated by quantitative reverse transcription?polymerase chain reaction (qRT?PCR) and correlated with immunohistological observations for four T1D pancreases (collected 5 days, 9 months, 8 and 10 years after diagnosis) and for purified islets from two of them. Collectively, the expression profile of immune response and inflammatory genes confirmed the current views on the immunopathogenesis of diabetes and showed similarities with other autoimmune diseases; for example, an interferon signature was detected. The data also supported the concept that the autoimmune process is maintained and balanced partially by regeneration and regulatory pathway activation, e.g. non-classical class I human leucocyte antigen and leucocyte immunoglobulin-like receptor, subfamily B1 (LILRB1). Changes in gene expression in islets were confined mainly to endocrine and neural genes, some of which are T1D autoantigens. By contrast, these islets showed only a few overexpressed immune system genes, among which bioinformatic analysis pointed to chemokine (C-C motif) receptor 5 (CCR5) and chemokine (CXC motif) receptor 4) (CXCR4) chemokine pathway activation. Remarkably, the expression of genes of innate immunity, complement, chemokines, immunoglobulin and regeneration genes was maintained or even increased in the long-standing cases. Transcriptomic data favour the view that T1D is caused by a chronic inflammatory process with a strong participation of innate immunity that progresses in spite of the regulatory and regenerative mechanisms.
ER  - 

AU  - Van de Walle, Gerlinde R.
AU  - De Schauwer, Catharina
AU  - Fortier, Lisa A.
C7  - pp. 297-310
TI  - Mesenchymal Stem Cell Therapy
SN  - 9781118558874
UR  - https://doi.org/10.1002/9781119086512.ch31
DO  - doi:10.1002/9781119086512.ch31
SP  - 297-310
KW  - equine MSC
KW  - equine MSC
KW  - equine regenerative medicine
KW  - mesenchymal stem cell therapy
PY  - 2010
AB  - Summary The use of mesenchymal stem cell (MSC) for the treatment of equine injuries and diseases holds immense potential, and is expanding from its original application in orthopedics into the treatment of ischemic, inflammatory, and neurologic disorders. The use of MSC for primary tissue regeneration was initially advocated on the basis of their ability to differentiate into various tissue types. As such, the regeneration of damaged tissues would be directly stimulated, since injected MSC colonize the injury site, differentiate into the appropriate mesenchymal tissue type, and affect repair. Since 2003, the clinical use of MSC has exploded, with thousands of horses now being treated worldwide. Demonstrating true efficacy should be a collective goal of the equine veterinary community, by performing clinical trials that include a sufficient amount of similar cases, and a consistent and standardized panel of objective outcome measures.
ER  - 

TY  - JOUR
AU  - Abecassis, Michael M.
AU  - Segev, Dorry L.
TI  - Transplantation at the Crossroads
JO  - American Journal of Transplantation
VL  - 11
IS  - s1
SN  - 9781118558874
UR  - https://doi.org/10.1111/j.1600-6143.2010.03391.x
DO  - doi:10.1111/j.1600-6143.2010.03391.x
SP  - 50
EP  - 90
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Sessions - Late Breaking
JO  - Transplant International
VL  - 24
IS  - s2
SN  - 9781118558874
UR  - https://doi.org/10.1111/j.1432-2277.2011.01352.x
DO  - doi:10.1111/j.1432-2277.2011.01352.x
SP  - 322
EP  - 352
PY  - 2011
ER  - 

TY  - JOUR
TI  - Invited Speaker Abstracts
JO  - American Journal of Reproductive Immunology
VL  - 67
IS  - s1
SN  - 9781118558874
UR  - https://doi.org/10.1111/j.1600-0897.2012.01129.x
DO  - doi:10.1111/j.1600-0897.2012.01129.x
SP  - 1
EP  - 22
PY  - 2012
ER  - 

TY  - JOUR
TI  - Presentation Abstracts
JO  - Transplant International
VL  - 23
IS  - s2
SN  - 9781118558874
UR  - https://doi.org/10.1111/j.1432-2277.2010.01152.x
DO  - doi:10.1111/j.1432-2277.2010.01152.x
SP  - 3
EP  - 23
PY  - 2010
ER  - 

TY  - JOUR
AU  - Baksh, D.
AU  - Song, L.
AU  - Tuan, R. S.
TI  - Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy
JO  - Journal of Cellular and Molecular Medicine
VL  - 8
IS  - 3
SN  - 9781118558874
UR  - https://doi.org/10.1111/j.1582-4934.2004.tb00320.x
DO  - doi:10.1111/j.1582-4934.2004.tb00320.x
SP  - 301
EP  - 316
KW  - mesenchymal stem cells
KW  - stem cell niche
KW  - differentiation
KW  - Wnt
KW  - gene therapy
PY  - 2004
AB  - Abstract A considerable amount of retrospective data is available that describes putative mesenchymal stem cells (MSCs). However, there is still very little knowledge available that documents the properties of a MSC in its native environment. Although the precise identity of MSCs remains a challenge, further understanding of their biological properties will be greatly advanced by analyzing the mechanisms that govern their self-renewal and differentiation potential. This review begins with the current state of knowledge on the biology of MSCs, specifically with respect to their existence in the adult organism and postulation of their biological niche. While MSCs are considered suitable candidates for cell-based strategies owing to their intrinsic capacity to self-renew and differentiate, there is currently little information available regarding the molecular mechanisms that govern their stem cell potential. We propose here a model for the regulation of MSC differentiation, and recent findings regarding the regulation of MSC differentiation are discussed. Current research efforts focused on elucidating the mechanisms regulating MSC differentiation should facilitate the design of optimal in vitro culture conditions to enhance their clinical utility cell and gene therapy.
ER  - 
